CNS Pharmaceuticals Quote - CNSP

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.1055

Bid

0.1055

Offer

0.1081

Volume

2,823,280

0.1032 Day's Range 0.1126

0.0955 52 Week Range 70.00

Market Cap

6.065M

Previous Close

0.108

Open

0.1085

Last Trade

0.1075

Last Trade Time

09:44:42

Financial Volume

US$ 309,638

VWAP

0.109673

Average Volume (3m)

16,612,645

Shares Outstanding

57,486,706

Dividend Yield

PE Ratio

-0.34

Earnings Per Share (EPS)

-0.33

Revenue

Net Profit

-18.85M

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of ... CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cnspharma.com

Headquarters

Carson City, Nevada, USA

Founded

CNS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CNSP. The last closing price for CNS Pharmaceuticals was US$0.11. Over the last year, CNS Pharmaceuticals shares have traded in a share price range of US$ 0.0955 to US$ 70.00.

CNS Pharmaceuticals currently has 57,486,706 shares in issue. The market capitalisation of CNS Pharmaceuticals is US$6.21 million. CNS Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.34.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0031	3.02734375	0.1024	0.125	0.1004	6679683	0.11083127	CS
4	-0.0175	-14.2276422764	0.123	0.125	0.0957	4027135	0.10966449	CS
12	-0.0354	-25.1242015614	0.1409	0.3699	0.0957	16612645	0.13500017	CS
26	-1.8845	-94.6984924623	1.99	4	0.0955	10670797	0.24963386	CS
52	-57.3945	-99.8165217391	57.5	70	0.0955	5718392	0.8176927	CS
156	-1334.8945	-99.9920973783	1335	2070	0.0955	2468812	81.15016526	CS
260	-5744.8945	-99.9981636205	5745	8430	0.0955	1692256	535.87070703	CS

CNSP - Frequently Asked Questions (FAQ)

What is the current CNS Pharmaceuticals share price?

The current share price of CNS Pharmaceuticals is US$ 0.1055

How many CNS Pharmaceuticals shares are in issue?

CNS Pharmaceuticals has 57,486,706 shares in issue

What is the market cap of CNS Pharmaceuticals?

The market capitalisation of CNS Pharmaceuticals is USD 6.21M

What is the 1 year trading range for CNS Pharmaceuticals share price?

CNS Pharmaceuticals has traded in the range of US$ 0.0955 to US$ 70.00 during the past year

What is the PE ratio of CNS Pharmaceuticals?

The price to earnings ratio of CNS Pharmaceuticals is -0.34

What is the reporting currency for CNS Pharmaceuticals?

CNS Pharmaceuticals reports financial results in USD

What is the latest annual profit for CNS Pharmaceuticals?

The latest annual profit of CNS Pharmaceuticals is USD -18.85M

What is the registered address of CNS Pharmaceuticals?

The registered address for CNS Pharmaceuticals is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703

What is the CNS Pharmaceuticals website address?

The website address for CNS Pharmaceuticals is www.cnspharma.com

Which industry sector does CNS Pharmaceuticals operate in?

CNS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CREVCarbon Revolution Public Ltd	US$ 9.20 (136.50%)	475.47k
NCRANocera Inc	US$ 1.47 (65.08%)	3.59M
MYNAMynaric AG	US$ 0.6599 (50.10%)	6.72M
BNOXBionomics Ltd	US$ 0.3649 (44.17%)	5.99M
TIVCTivic Health Systems Inc	US$ 0.306 (36.36%)	6.44M
SLGLSol Gel Technologies Ltd	US$ 1.14 (-30.91%)	3.5M
FRESFresh2 Group Ltd	US$ 0.60 (-29.41%)	65.12k
ANEBAnebulo Pharmaceuticals Inc	US$ 1.0201 (-18.39%)	2.65k
JZXNJiuzi Holdings Inc	US$ 1.45 (-12.12%)	312
PAVMPAVmed Inc	US$ 0.5703 (-11.58%)	1.08M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.4379 (8.63%)	13.3M
DRCTDirect Digital Holdings Inc	US$ 6.27 (14.00%)	10.78M
MYNAMynaric AG	US$ 0.6599 (50.10%)	6.72M
TIVCTivic Health Systems Inc	US$ 0.306 (36.36%)	6.44M
BNOXBionomics Ltd	US$ 0.3649 (44.17%)	5.99M